AromAb Information

AromAb is a Netherlands-based biotech company developing APPC™ – Aromatic Porous Precipitated Complex – a scalable, non-chromatographic, ligand-free purification platform designed to reduce the cost, complexity, and scalability limitations of antibody manufacturing. With more than $200B being invested in global biologics manufacturing capacity, the industry faces a critical need for purification infrastructure that can support both today’s high-volume IgG antibodies and next-generation formats, including IgA, IgM, Fc-fusion proteins, and other complex biologics. APPC™ is designed to operate at neutral pH, simplify downstream workflows, and support faster, gentler, and more cost-effective purification across established and emerging antibody formats. With patent protection in multiple regions and validation by industry partners, AromAb is advancing toward pilot-scale development and engaging with investors, biopharma companies, CDMOs, and strategic partners. Learn more > https://aromab.tech/